ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors
- 1 March 2015
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 75 (5) , 824-834
Abstract
The endoplasmic reticulum aminopeptidase ERAP1 regulates innate and adaptive immune responses by trimming peptides for presentation by MHC class I (MHC-I) molecules. Herein, we demonstrate that genetic or pharmacological inhibition of ERAP1 on human tumor cell lines perturbs their ability to engage several classes of inhibitory receptors by their specific ligands, including killer cell Ig-like receptors (KIR) by classical MHC-I–peptide (pMHC-I) complexes and the lectin-like receptor CD94-NKG2A by nonclassical pMHC-I complexes, in each case leading to natural killer (NK) cell killing. The protective effect of pMHC-I complexes could be restored in ERAP1-deficient settings by the addition of known high-affinity peptides, suggesting that ERAP1 was needed to positively modify the affinity of natural ligands. Notably, ERAP1 inhibition enhanced the ability of NK cells to kill freshly established human lymphoblastoid cell lines from autologous or allogeneic sources, thereby promoting NK cytotoxic activity against target cells that would not be expected because of KIR–KIR ligand matching. Overall, our results identify ERAP1 as a modifier to leverage immune functions that may improve the efficacy of NK cell–based approaches for cancer immunotherapy. Cancer Res; 75(5); 824–34. ©2015 AACR.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94Proceedings of the National Academy of Sciences, 2013
- Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cellsFrontiers in Immunology, 2013
- Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to CancerInternational Journal of Molecular Sciences, 2012
- Peptide antagonism as a mechanism for NK cell activationProceedings of the National Academy of Sciences, 2010
- 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infectionNature Immunology, 2010
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityBlood, 2009
- Evolutionary struggles between NK cells and virusesNature Reviews Immunology, 2008
- HLA alleles determine differences in human natural killer cell responsiveness and potencyProceedings of the National Academy of Sciences, 2008
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001